This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Table 2.4 Percent of surgical discharges with postoperative venous thromboembolic events, United States, 2004 and 2005a |
| Population group |
2005 |
2004 |
| Exposed |
Adverse events |
Percent |
Standard error |
Exposed |
Adverse events |
Percent |
Standard error |
| Total |
|
5,994 |
62 |
1.03 |
0.13 |
5,752 |
65 |
1.13 |
0.14 |
| Age |
Under 65 |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
| 65-74 |
2,452 |
19 |
0.77 |
0.18 |
2,312 |
17 |
0.74 |
0.18 |
| 75-84 |
2,031 |
25 |
1.23 |
0.24 |
2,004 |
34 |
1.70 |
0.29 |
| 85 and over |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
| Gender |
Male |
2,641 |
28 |
1.06 |
0.20 |
2,554 |
35 |
1.37 |
0.23 |
| Female |
3,353 |
34 |
1.01 |
0.17 |
3,198 |
30 |
0.94 |
0.17 |
| Race |
White |
5,236 |
55 |
1.05 |
0.14 |
5,087 |
56 |
1.10 |
0.15 |
| Black |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
| Other |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
| Diabetes |
Yes |
1,678 |
21 |
1.25 |
0.27 |
1,541 |
18 |
1.17 |
0.27 |
| No |
4,316 |
41 |
0.95 |
0.15 |
4,211 |
47 |
1.12 |
0.16 |
| Obesity |
Yes |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
| No |
5,270 |
58 |
1.10 |
0.14 |
5,064 |
56 |
1.11 |
0.15 |
| Cerebrovascular disease |
Yes |
DSU |
DSU |
DSU |
DSU |
1,027 |
13 |
1.27 |
0.35 |
| No |
4,929 |
53 |
1.08 |
0.15 |
4,725 |
52 |
1.10 |
0.15 |
| CHF/pulmonary edema |
Yes |
945 |
15 |
1.59 |
0.41 |
956 |
17 |
1.78 |
0.43 |
| No |
5,049 |
47 |
0.93 |
0.14 |
4,796 |
48 |
1.00 |
0.14 |
| COPD |
Yes |
1,342 |
17 |
1.27 |
0.31 |
1,306 |
20 |
1.53 |
0.34 |
| No |
4,652 |
45 |
0.97 |
0.14 |
4,446 |
45 |
1.01 |
0.15 |
| Smoking |
Yes |
845 |
12 |
1.42 |
0.41 |
DSU |
DSU |
DSU |
DSU |
| No |
5,149 |
50 |
0.97 |
0.14 |
4,902 |
56 |
1.14 |
0.15 |
| Cancer |
Yes |
DNA |
DNA |
DNA |
DNA |
1,623 |
24 |
1.48 |
0.30 |
| No |
DNA |
DNA |
DNA |
DNA |
4,129 |
41 |
0.99 |
0.15 |
| Corticosteroids |
Yes |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
DSU |
| No |
5,704 |
57 |
1.00 |
0.13 |
5,494 |
60 |
1.09 |
0.14 |
| Coronary artery disease |
Yes |
2,146 |
21 |
0.98 |
0.21 |
2,133 |
35 |
1.64 |
0.28 |
| No |
3,848 |
41 |
1.07 |
0.17 |
3,619 |
30 |
0.83 |
0.15 |
| Renal disease |
Yes |
1,105 |
18 |
1.63 |
0.38 |
947 |
20 |
2.11 |
0.47 |
| No |
4,889 |
44 |
0.90 |
0.14 |
4,805 |
45 |
0.94 |
0.14 |
a Data include Medicare beneficiaries discharged from January to December. Venous thromboembolic events include 30-day postoperative readmissions for pneumonia and venous thromboembolic events. Readmissions were not counted for the 2004 data because the data were not available at that time.
DNA - Data have not been analyzed.
DSU - Data do not meet the criteria for statistical reliability, data quality, or confidentiality.
Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease.
Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.